REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Research/Paper
Back to Research Library
PubMedReview

Adipose tissue ageing: implications for metabolic health and lifespan.

Wang Guan, Song Anying, Wang Qiong A
Nature reviews. Endocrinology2025DOI: 10.1038/s41574-025-01142-8

Quality Score

8/10

Citations

0

Subjects

Non-Human

Peptide Contacts Analysis

Study Design

Review papers serve a critical role in synthesizing disparate findings into a coherent narrative. For rapidly evolving fields like peptide therapeutics, reviews help researchers and practitioners identify consensus and controversy.

Our Assessment

Quality Assessment: 8/10 — This paper meets our highest quality thresholds. The methodology is well-designed, the statistical analysis is appropriate, and the conclusions are well-supported by the data presented. This is a reference-grade study for the peptides it covers.

Findings in Context

These findings advance our understanding of the peptides studied in meaningful ways.

On the Limitations

Every study has limitations, and being transparent about them is what separates good science from hype. These limitations don't invalidate the findings — they define the boundaries of what we can confidently conclude.

The Takeaway

Bottom line: Strong methodology makes this a valuable addition to the these peptides evidence base. The findings here should inform future clinical trial design.

Key Findings

The review comprehensively examines how adipose tissue changes during ageing and its impact on metabolic health, including the role of various cell types within adipose tissue. It also explores potential interventions to mitigate age-related diseases.

Limitations

As a review paper, it does not present new experimental data but rather synthesizes existing literature, which may not capture all recent developments or nuances in the field.

How to Interpret This Research

1

Look for the sample size — larger studies produce more reliable results. Single-digit sample sizes warrant caution.

2

Check whether the study was funded by a pharmaceutical company or conducted independently, as funding sources can influence study design and reporting.

3

Reviews are only as good as the studies they include. Check whether the review examined study quality or simply tallied results.

4

Look for discussion of publication bias — studies with negative results are less likely to be published, which can skew review conclusions.

5

Always consult a qualified healthcare provider before making treatment decisions based on research findings. Published research is not a substitute for personalized medical advice.

Peptide Contacts Analysis

An overview of how adipose tissue changes with age and its implications for metabolic health, focusing on potential therapeutic strategies.

The Aging Fat: How Changes in Adipose Tissue Impact Metabolic Health

Published: May 16, 2026 | Source: Nature reviews. Endocrinology (2025) | Category: Peptide Therapy and Metabolism

Overview

A new review published in Nature Reviews Endocrinology explores how adipose tissue changes as we age and its implications for metabolic health. This comprehensive analysis highlights the role of various cell types within fat tissue and potential therapeutic strategies to mitigate age-related diseases.

Study Background

Until recently, little attention was paid to the aging process of adipose tissue despite its crucial role in energy homeostasis and insulin sensitivity. Researchers aimed to fill this gap by summarizing existing literature on how different types of adipose tissue change over time and their impact on metabolic health and lifespan.

What the Research Found

The review details significant changes in white and thermogenic fat tissues as we age, affecting cell types such as adipocytes (fat cells), immune cells, and senescent cells. These changes can lead to conditions like fatty liver disease and cardiovascular diseases. The study also highlights potential interventions, including caloric restriction, metformin, GLP-1 receptor agonists, and senolytics, which may help mitigate these age-related issues.

What This Means for Peptide Users

For those using peptides or considering them as part of a health regimen, understanding how adipose tissue changes with age is crucial. While the review does not focus on peptide therapy specifically, it underscores the importance of metabolic health and suggests potential pathways that could be targeted by future peptide-based interventions.

Limitations and Caveats

As this paper is a review and not an experimental study, it synthesizes existing literature without presenting new data. This means some recent developments or specific nuances in adipose tissue research might not be fully captured. Additionally, while the suggested interventions show promise, their efficacy and safety need further investigation.

How This Compares to Previous Research

This review builds on previous studies that have identified changes in adipose tissue with aging but provides a more comprehensive analysis by integrating findings from various cell types within fat tissues. It also offers an updated perspective on potential therapeutic strategies that could be beneficial for metabolic health and longevity.

Our Analysis

PeptideVault views this review as a valuable resource for understanding the complex interplay between adipose tissue changes and age-related diseases. The authors effectively summarize current knowledge while identifying gaps in research, which can guide future studies. However, the lack of new experimental data means that some aspects of the findings remain speculative.

Key Takeaways

  • Adipose Tissue Remodeling: Adipose tissue undergoes significant changes as we age, impacting metabolic health and disease risk.
  • Cellular Changes: Various cell types within adipose tissue are affected by aging, influencing overall fat function and systemic metabolism.
  • Potential Interventions: Caloric restriction, metformin, GLP-1 receptor agonists, and senolytics show promise in mitigating age-related metabolic issues.

Original Source

Citation: Wang Guan, Song Anying, Wang Qiong A (2025). Adipose tissue ageing: implications for metabolic health and lifespan.. Nature reviews. Endocrinology. DOI: 10.1038/s41574-025-01142-8

Access: https://pubmed.ncbi.nlm.nih.gov/40550948/

---

This article is for informational and research purposes only. PeptideVault summarizes and analyzes published research. Always consult a licensed healthcare provider.

Editor's Note

This analysis was written by the Peptide Contacts research team to make complex findings accessible to the peptide community. We encourage readers to review the source paper for full methodology and data.

Citation

Wang Guan, Song Anying, Wang Qiong A. (2025). Adipose tissue ageing: implications for metabolic health and lifespan.. Nature reviews. Endocrinology. https://doi.org/10.1038/s41574-025-01142-8

View full text on PubMed

Related Papers

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Mendias Christopher L et al.· Sports medicine (Auckland, N.Z.)· 2026Review

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.

Yuan Claire et al.· International journal of molecular sciences· 2026Review

Carbonless amino acids and a carbonless GHK peptide.

Skurski Piotr et al.· Physical chemistry chemical physics : PCCP· 2026Review

The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.

Wen Huijun et al.· Biogerontology· 2026Review

Glycyl-L-histidyl-L-lysine-Cu2

Hu Jing et al.· European journal of pharmacology· 2026Review

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

Mayfield Cory K et al.· The American journal of sports medicine· 2026Review

Explore Further

Research Library

Browse all indexed papers

Research Guides

Plain-language peptide guides

This content is derived from peer-reviewed research for educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide-based therapy.